University Hospital Southampton Study Finds Persistent PPD Contact Allergy
- Paraphenylenediamine (PPD) contact allergy remains a persistent clinical concern, affecting 4.3% of patients who undergo specialized patch testing, according to a retrospective review published online September 22 in...
- Led by corresponding author Zara Ali, investigators evaluated patch test outcomes from January 2018 to January 2025 to determine the clinical presentation, cross-reactivity, and post-diagnosis trajectories of affected...
- Hair dye accounted for 77% of exposures, or 43 cases, while eight patients — representing 14% of the cohort — encountered the allergen through occupational exposure as hairdressers...
Paraphenylenediamine (PPD) contact allergy remains a persistent clinical concern, affecting 4.3% of patients who undergo specialized patch testing, according to a retrospective review published online September 22 in Contact Dermatitis. Researchers at University Hospital Southampton examined clinic outcomes and found that while hair dye represents the primary exposure route, a majority of products marketed as “PPD-free” still harbor closely related aromatic-amine derivatives capable of triggering allergic contact dermatitis.
Patch Testing Results and Patient Demographics
Led by corresponding author Zara Ali, investigators evaluated patch test outcomes from January 2018 to January 2025 to determine the clinical presentation, cross-reactivity, and post-diagnosis trajectories of affected individuals. Out of 1,306 patients tested with a commercial allergen panel containing PPD in a petrolatum base, 56 patients tested positive. The mean age at diagnosis stood at 49 years, and 82% of those affected were women.
Hair dye accounted for 77% of exposures, or 43 cases, while eight patients — representing 14% of the cohort — encountered the allergen through occupational exposure as hairdressers or hairdressing students. Patients endured a mean symptom duration of 4.9 years prior to receiving a formal diagnosis. Clinicians documented moderate or severe disease in 54 patients, equal to 96% of the positive cohort, with eczematous dermatitis emerging as the most frequent clinical presentation in 91% of cases.
Cross-Reactivity and Market Labeling Concerns
The study also evaluated cross-reactivity to related chemicals. Among 37 patients tested for para-toluenediamine alongside PPD, roughly a quarter, or 27%, showed a positive reaction to para-toluenediamine. A structured web search conducted in October 2025 across the leading 50 hits for commercial dye products in the United Kingdom revealed widespread misleading labeling. Of seven permanent dyes marketed as “PPD-free,” only one lacked PPD, para-toluenediamine, aminophenols, and related derivatives.
Out of three “PPD-free” eyebrow and eyelash tints reviewed, two still contained para-toluenediamine and aminophenols. The third prompted a UK product safety report for deceptively marketing a para-toluenediamine-containing product as free of PPD.
Follow-Up Outcomes and Regulatory Recommendations
Telephone follow-ups completed with 31 patients, representing 55% of the positive cohort, showed that avoidance yields substantial clinical improvement. Exactly 24 patients, or 77%, reported complete or near-complete remission after eliminating PPD-containing items from their routines. All five patients who faced occupational exposure successfully changed careers or left the workforce entirely.
Improved regulatory oversight and mandatory disclosure of all aromatic-amine derivatives on product labelling are required to protect consumers and support clinicians in advising patients.
Zara Ali et al.
The researchers also advocated for broader efforts to include aromatic-amine derivatives in European Union and UK cosmetic safety databases. They concluded that developing validated patient-education materials and implementing occupational-screening protocols could further reduce the overall disease burden for sensitized individuals.